Objective: Our objective was to identify the patterns of opioid use among pregnant women enrolled in RI Medicaid. Methods: This study used linked RI Medicaid and RI Birth Certificate data from 01/01/2006 to 12/31/2016. We examined temporal trends of prescription opioid dispensings and identified risk factors associated with opioids use during pregnancy. Results: Among 25,500 RI Medicaid enrolled pregnant women who delivered a live baby from 2008 to 2016, 1,914 (7.5%) received at least one prescription for an opioid medication during pregnancy, 810 (3.2%) were during the first trimester, 633 (2.5%) during the second trimester, and 866 (3.4%) during the third trimester. Of these, 213 (0.8%) women received 3 or more opioids during pregnancy. T...
International audienceBackground: Recent studies show a rapid growth among pregnant women using high...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Introduction and Objective: Receipt of opioid agonist treatment during early and late pregnancy for ...
Prescription opioid use during pregnancy has been associated with poor outcomes for mothers and infa...
Consequences of the opioid epidemic in the general population have been widely reported in peer-revi...
Objective: Opioid prescription rates in North America have increased dramatically over the past two ...
Background: Opioid use and opioid use disorder (OUD) during pregnancy are significant issues in the ...
Background: The prevalence of opioid use in pregnancy has increased sharply in recent years. Kentuck...
Background: Nationally, opioid prescribing for chronic noncancer pain has increased significantly ov...
OBJECTIVE: To characterize prescription and other medication use in a geographically and ethnical...
Background: Opioid use has increased dramatically in North America. The safety of opioids in pregnan...
OBJECTIVE: To estimate treatment and postpartum health care utilization among pregnant persons with ...
Introduction It is important to investigate the use of prescription opioids during pregnancy to gain...
OBJECTIVE: The purpose of this study was to provide information on the prevalence of the use of pres...
Objective: To provide absolute and relative risk estimates of neonatal abstinence syndrome (NAS) bas...
International audienceBackground: Recent studies show a rapid growth among pregnant women using high...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Introduction and Objective: Receipt of opioid agonist treatment during early and late pregnancy for ...
Prescription opioid use during pregnancy has been associated with poor outcomes for mothers and infa...
Consequences of the opioid epidemic in the general population have been widely reported in peer-revi...
Objective: Opioid prescription rates in North America have increased dramatically over the past two ...
Background: Opioid use and opioid use disorder (OUD) during pregnancy are significant issues in the ...
Background: The prevalence of opioid use in pregnancy has increased sharply in recent years. Kentuck...
Background: Nationally, opioid prescribing for chronic noncancer pain has increased significantly ov...
OBJECTIVE: To characterize prescription and other medication use in a geographically and ethnical...
Background: Opioid use has increased dramatically in North America. The safety of opioids in pregnan...
OBJECTIVE: To estimate treatment and postpartum health care utilization among pregnant persons with ...
Introduction It is important to investigate the use of prescription opioids during pregnancy to gain...
OBJECTIVE: The purpose of this study was to provide information on the prevalence of the use of pres...
Objective: To provide absolute and relative risk estimates of neonatal abstinence syndrome (NAS) bas...
International audienceBackground: Recent studies show a rapid growth among pregnant women using high...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Introduction and Objective: Receipt of opioid agonist treatment during early and late pregnancy for ...